BIOS Fund III, LP
SEC CIK 1791917 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGTX | COGNITION THERAPEUTICS INC | Dir, 10% | 48.5K | — | — | 2 | 2023-11-08 | 2025-06-18 |
Most active insiders at CGTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Doyle John Brendan | CFO | $11.3K | — |
| 2 | Caggiano Anthony | Chief Medical Off | $11.1K | — |
| 3 | Ricciardi Lisa | CEO, Pres, Dir | $10.1K | — |
| 4 | Wallace Peggy | Dir | — | — |
| 5 | Fletcher Aaron G.L. | Dir, 10% | — | — |
| 6 | Khattar Jack A. | Dir | — | — |
| 7 | Monia Brett P | Dir | — | — |
| 8 | RICHSTONE ELLEN B | Dir | — | — |
BIOS Fund III, LP made no open-market trades at CGTX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-20 | 2025-06-18 | CGTX | COGNITION THERAPEUTICS INC | BIOS Fund III, LP | Dir, 10% | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 |
| I | 2023-11-13 | 2023-11-08 | CGTX | COGNITION THERAPEUTICS INC | BIOS Fund III, LP | Dir, 10% | A - Grant | $1.05 | +500.1K | 500.1K | New | +$525.1K |
Purchase Sale Sale after option exercise All abbreviations